Cardinal Health Unveils Advanced Compression System for Patients
Cardinal Health Launches Next-Gen Kendall SCD SmartFlow™ Compression System
Cardinal Health is proud to announce the exciting launch of its Kendall SCD SmartFlow™ Compression System, a cutting-edge solution in the fight against deep vein thrombosis (DVT) and pulmonary embolism. This next generation of the Kendall Compression Series is focused on improving both clinician and patient experiences, delivering advanced care for those at risk.
Innovative Features and Benefits
This state-of-the-art system utilizes clinically proven technology that provides customized and intermittent pneumatic compression (IPC). This technology is specifically designed to increase blood flow in patients who are at risk for venous thromboembolism (VTE) events. By preventing these dangerous conditions, the Kendall SCD SmartFlow™ Compression System greatly enhances blood circulation and effectively addresses pain and swelling associated with venous stasis.
Enhanced Patient Care
According to Steve Marshall, Senior Vice President of Global Product Marketing at Cardinal Health, "We're committed to introducing innovations that enhance compression therapy. Our reimagined Kendall SCD device offers reliable compression treatments, allowing healthcare providers to dedicate more time to what truly matters: patient care." This device is not just an advancement in technology; it is a tool designed to provide comfort and relief to patients suffering from inadequate blood flow.
Advanced Technology Integration
The Kendall SCD SmartFlow™ Compression System integrates Vascular Refill Detection (VRD) technology that features a unique sequential, gradient sleeve design. This allows the device to move more blood per hour than traditional compression systems. The intelligent VRD technology fine-tunes the compression cycles to correspond with individual vascular refill times. This customization ensures patients benefit from more effective compression cycles and reduced stasis over time.
Commitment to Innovation
Complementing the VRD technology are additional features—including the proprietary Patient Sensing™ Technology, which enables automatic detection of the therapy application. This system activates an alert whenever there’s no patient detected or if the compression sleeves are not correctly positioned.
Marshall further emphasized the importance of this release by noting, "For 40 years, our Kendall SCD compression portfolio has been trusted by healthcare providers to help protect patients from VTE events. With this new system, we reaffirm our commitment to ongoing innovation in compression therapy." The intuitive design and user-friendly features of this product signify a significant leap forward in patient care.
Availability and Future Plans
The Cardinal Health Kendall SCD SmartFlow™ Compression System is now available for health systems throughout the U.S., with plans to expand its availability internationally in the near future. This expansion is a vital step in providing healthcare solutions that are both innovative and accessible to diverse patient populations.
About Cardinal Health
Cardinal Health operates as a leading distributor of pharmaceuticals and specialty medical products. The company is known for its extensive range of products and services that cover pharmaceuticals, medical supplies, laboratory products, and home-health solutions. Cardinal Health’s commitment to improving lives through innovative solutions continues to drive its success in the healthcare market.
Frequently Asked Questions
What is the Kendall SCD SmartFlow™ Compression System?
The Kendall SCD SmartFlow™ Compression System is a new compression therapy device designed by Cardinal Health to prevent VTE events and enhance blood circulation.
How does the VRD technology improve patient care?
VRD technology customizes compression cycles based on a patient's vascular refill time, effectively increasing the number of compression cycles over time and reducing stasis.
When will the system be available internationally?
The system is set to be offered internationally in early 2025, following its launch in the U.S.
What role does Cardinal Health play in the medical field?
Cardinal Health is a provider of pharmaceuticals, medical and laboratory products, and services that focus on performance and patient-centered solutions.
How long has Cardinal Health been in the compression therapy business?
Cardinal Health has a rich history in compression therapy, with the Kendall SCD compression portfolio serving healthcare providers for over 40 years.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.